In humans and animal models, high plasma concentrations of apolipoprotein (apo) E are associated with hypertriglyceridemia. It has been shown that overexpression of human wild-type (WT) apoE4 in apoE-deficient mice induces hypertriglyceridemia. In contrast, overexpression of an apoE4 variant, apoE4-mut1 (apoE4(L261A, W264A, F265A, L268A, V269A)), does not induce hypertriglyceridemia and corrects hypercholesterolemia. Furthermore, overexpression of another variant, apoE4-mut2 (apoE4(W276A, L279A, V280A, V283A)), induces mild hypertriglyceridemia and does not correct hypercholesterolemia. To better understand how these mutations improve the function of apoE4, we investigated the conformation and stability of apoE4-mut1 and apoE4-mut2 and their binding to dimyristoyl phosphatidylcholine (DMPC) vesicles and to triglyceride (TG)-rich emulsion particles. We found that the mutations introduced in apoE4-mut1 lead to a more stable and compactly folded conformation of apoE4. These structural changes are associated with a slower rate of solubilization of DMPC vesicles by apoE4-mut1 and reduced binding of the protein to emulsion particles as compared to WT apoE4. Under conditions of apoE4 overexpression, the reduced binding of apoE4-mut1 to TG-rich lipoprotein particles may facilitate the lipolysis of these particles and may alter the conformation of the lipoprotein-bound apoE in a way that favors the efficient clearance of the lipoprotein remnants. Mutations introduced in apoE4-mut2 result in smaller structural alterations compared to those observed in apoE4-mut1. The slightly altered structural properties of apoE4-mut2 are associated with slightly reduced binding of this protein to TG-rich lipoprotein particles and milder hypertriglyceridemia as compared to WT apoE4.Human apolipoprotein E (apoE) is a key component of the lipoprotein transport system and is required for the maintenance of lipid homeostasis in the circulation and the brain (1-3). In humans, there are three natural apoE isoforms that differ from each other by amino acid substitutions at positions 112 and 158. ApoE3 is the most common isoform; apoE2 is associated with type III hyperlipoproteinemia, while apoE4 (Arg-112, Arg-158) is associated with high plasma cholesterol level and an increased risk for both coronary heart disease and Alzheimer's diseases (4-7). ApoE is one of the major protein constituents of triglyceride (TG)-rich chylomicrons and very low density lipoproteins
NIH-PA Author ManuscriptNIH-PA Author Manuscript NIH-PA Author Manuscript (VLDL). In the bloodstream, these TGrich lipoproteins are converted into remnants through hydrolysis of their core TG by lipoprotein lipase (LPL). At physiological concentrations, apoE mediates the hepatic uptake of the lipoprotein remnants via the low density lipoprotein (LDL) receptor and thereby, regulates plasma lipid levels and contributes to atheroprotection (1-3, 7). However, elevated plasma apoE levels in humans and in animal models have been positively correlated with hypertriglyceridemia (8-1...